Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors.

S AntoniniR PedersiniM F BirtoloN L BaruchF CarroneS JaafarA CiafardiniD CosentiniM LaganàR TorrisiD FarinaL LeonardiL BalzariniW VenaA C BossiA ZambelliAndrea Gerardo LaniaA BerrutiGiovanna Mantovani

Published in: Journal of endocrinological investigation (2023)

TBS variation predicts fracture risk in AIs treated women. Denosumab is effective to induce early increase of TBS and reduction in risk of VFs.

Keyphrases

bone mineral density
postmenopausal women
polycystic ovary syndrome
body composition
pregnancy outcomes
breast cancer risk
giant cell
cervical cancer screening
hip fracture
metabolic syndrome
soft tissue
pregnant women
adipose tissue